Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.